ocunexus.comHealthcareFounded: 1900Funding to Date: $144.36MM
Ocunexus Therapeutics is a biotechnology company focused on inflammasome modulation for treatment of Dry Age-related Macular Degeneration and Diabetic Retinopathy.
For more details on financing and valuation for OcuNexus Therapeutics, register or login.
View Enterprise Value for OcuNexus Therapeutics.
To read this article and more news on OcuNexus Therapeutics, register or login.